Your browser doesn't support javascript.
loading
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study.
El-Habashy, Dina M; Wahid, Kareem A; He, Renjie; McDonald, Brigid; Rigert, Jillian; Mulder, Samuel J; Lim, Tze Yee; Wang, Xin; Yang, Jinzhong; Ding, Yao; Naser, Mohamed A; Ng, Sweet Ping; Bahig, Houda; Salzillo, Travis C; Preston, Kathryn E; Abobakr, Moamen; Shehata, Mohamed A; Elkhouly, Enas A; Alagizy, Hagar A; Hegazy, Amira H; Mohammadseid, Mustefa; Terhaard, Chris; Philippens, Marielle; Rosenthal, David I; Wang, Jihong; Lai, Stephen Y; Dresner, Alex; Christodouleas, John C; Mohamed, Abdallah Sherif Radwan; Fuller, Clifton D.
Afiliación
  • El-Habashy DM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wahid KA; Department of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt.
  • He R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McDonald B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rigert J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mulder SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lim TY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yang J; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ding Y; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Naser MA; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bahig H; Department of Radiation Oncology, Austin Health Melbourne, Australia.
  • Salzillo TC; Department of radiology, radiation oncology and nuclear medicine, Université de Montréal, Canada.
  • Preston KE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abobakr M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shehata MA; University of Houston College of Pharmacy, Houston, Texas, USA.
  • Elkhouly EA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Alagizy HA; Department of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt.
  • Hegazy AH; Department of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt.
  • Mohammadseid M; Department of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt.
  • Terhaard C; Department of Clinical Oncology and Nuclear Medicine, Menoufia University, Shebin Elkom, Egypt.
  • Philippens M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rosenthal DI; Department of Radiation Therapy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wang J; Department of Radiation Therapy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lai SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dresner A; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Christodouleas JC; Department of Head and Neck Surgery, Division of Surgery,The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mohamed ASR; Philips Healthcare MR Oncology, Cleveland, Ohio, USA.
  • Fuller CD; Elekta AB, Stockholm, Sweden.
medRxiv ; 2023 May 05.
Article en En | MEDLINE | ID: mdl-37205359
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos